Los programas de afiliados no están permitidos en España para la comercialización de servicios de inversion y captación de clientes por parte de terceros no autorizados
Abbott Laboratories | ABT.USX
United States - USD

Stock Exchange: NYSE

Symbol: ABT

Sector: Healthcare

Industry: Medical Devices

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories Stats

Previous close:Daily change:
117.13-1.02%
52-Week High:52-Week Low:
121.6499.71
Market Cap:Beta:
201.1 Billion0.72

Abbott Laboratories Key Financials

P/E Ratio:Revenues:Revenue Growth:Gross Margin:
35.237141.2 Billion4.90%55.91%
Dividend Yield:Net Income:Earnings Growth:Net Income Margin:
1.88%5.7 Billion14.60%13.99%
P/E Ratio:Revenues:
35.237141.2 Billion
Dividend Yield:Net Income:
1.88%5.7 Billion
Revenue Growth:Gross Margin:
4.90%55.91%
Earnings Growth:Net Income Margin:
14.60%13.99%
ParametersStocks Investing
Stock CurrencyUSD
Dividend PayingYes
Fractional SharesNo
Maximum Shares100 Shares
Tick value per 1 share0.01 USD
Trading Commission0%
Minimum Price Increment0.01
Limit and Stop Levels0.0
Negative balance protectionNo
Swap free days allowanceN/A
Own the underlying AssetNo
Platform symbolABT.USX
Disclaimer: This material is provided by third-party data sources as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in CFDs and Physical Stocks products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information presented here.
Advertencia de inversión de riesgo elevado: los contratos por diferencias («CFD») son productos financieros complejos que se operan con margen. Operar con CFD conlleva un grado de riesgo elevado. Podría perder todo su capital. Estos productos podrían no ser adecuados para todo el mundo; por lo tanto, debe estar seguro de que ha entendido los riesgos que implican. Si fuera necesario, solicite asesoramiento de un experto independiente y solo especule con fondos que pueda permitirse perder. Considere detenidamente si ese tipo de operación es adecuada para usted, teniendo en cuenta todas las circunstancias pertinentes, así como sus recursos personales. No recomendamos que los clientes registren todo el saldo de su cuenta para cumplir con los requisitos del margen. Los clientes pueden reducir su nivel de exposición solicitando un cambio del límite de apalancamiento. Para más información, consulte la Divulgación de riesgos de HYCM.
Renuncia de responsabilidad: el contenido de esta página tiene un carácter meramente informativo y no pretende ser una recomendación o un asesoramiento. Cualquier indicación de un rendimiento anterior o de un rendimiento anterior simulado incluida en anuncios publicados por HYCM no es un indicador de resultados futuros. El cliente asume la responsabilidad exclusiva de todos los negocios o inversiones que se realicen en HYCM. 
Restricciones regionales: no ofrecemos nuestros servicios a residentes de determinadas jurisdicciones como Afganistán, Bélgica, Hong Kong, Estados Unidos y algunas otras regiones. Para obtener más información, consulte nuestra
Centro de Ayuda

HYCM Limited is authorized and regulated under the Dubai Financial Services Authority with license number F000048.

Copyright © 2024 HYCM.